8-K - REPLIGEN CORP (0000730272) (Filer)
据 SEC EDGAR 8-K 文件，Repligen Corp（CIK 0000730272）于 2026-10-30 提交 8-K，报告期为 2026-10-29，涉及 Item 3.02 未注册股权销售、Item 8.01 其他事项及 Item 9.01 财务报表与附件，文件共 14 份文档。
报错 · 内容有误？请告诉我们。
Filing Date
2026-10-30
Accepted
2026-10-30 06:04:21
Documents
14
Period of Report
2026-10-29
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)
EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-14656 | Film No.: 261504272
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)
来源：SEC EDGAR 8-K · sec.gov